Skip to content

PBPHPortfolio Building Block World Pharma and Biotech Index ETF

Grow my moneyNewRanked #504 of 3,055 in this goal

Tracks the performance of the BITA Global Pharma and Biotech Select Index.

By Portfolio Building Block ETFs · Launched 2025

Annual Cost

0.13%

#539 of 6,040 · low cost

Fund Size

$1.0B

#1,174 of 6,040 · large

Return (1Y)

N/A

Track Record

10 months

#4,917 of 6,040 · young

Performance

Total-return NAV · USD
Growth of $10,000
$11,375+13.8%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Cap

Multi cap

Strategy

Index tracking

Focus

Biotech & Genomics

Index tracked

BITA Global Pharma and Biotech Select Index

Holdings

By weight

Concentration

Top 10 holdings = 0.6% of funddiversified

ELI LILLY & CO
0.1%
JOHNSON & JOHNSON
0.1%
ABBVIE INC
0.1%
ROCHE HOLDING AG-GENUSSCHEIN
0.1%
NOVARTIS AG-REG
0.0%
MERCK & CO. INC.
0.0%
ASTRAZENECA PLC
0.0%
NOVO NORDISK A/S-B
0.0%
AMGEN INC
0.0%
GILEAD SCIENCES INC
0.0%

Asset allocation

Stocks
99.8%
Cash
0.2%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-11.1%Mild

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Tracks the performance of the BITA Global Pharma and Biotech Select Index.
Strategy
Uses a passive management approach to track the BITA Global Pharma and Biotech Select Index, investing primarily in ordinary shares of companies in the pharmaceutical and biotechnology sectors with a market capitalization of at least $10 billion. The Fund invests at least 80% of its net assets in component securities of the Index, which includes companies listed on major stock exchanges in developed markets.
Inception date
November 25, 2025
Fund family
Portfolio Building Block ETFs

Next steps

Save PBPH to compare it with other funds, or start building a portfolio.

Data updated on 2026-09-18